Patent applications and USPTO patent grants for Lyotropic Therapeutics, Inc..The latest application filed is for "treatment using dantrolene".
Patent | Date |
---|---|
Treatment Using Dantrolene App 20210015796 - Anderson; David ;   et al. | 2021-01-21 |
Treatment using dantrolene Grant 10,821,098 - Anderson , et al. November 3, 2 | 2020-11-03 |
Treatment Using Dantrolene App 20190255021 - Anderson; David ;   et al. | 2019-08-22 |
Treatment using dantrolene Grant 10,314,822 - Anderson , et al. | 2019-06-11 |
Treatment Using Dantrolene App 20180125822 - Anderson; David ;   et al. | 2018-05-10 |
Treatment using dantrolene Grant 9,884,044 - Anderson , et al. February 6, 2 | 2018-02-06 |
Treatment using dantrolene Grant 9,789,090 - Anderson , et al. October 17, 2 | 2017-10-17 |
Treatment Using Dantrolene App 20170143677 - Anderson; David ;   et al. | 2017-05-25 |
Treatment using dantrolene Grant 9,603,840 - Anderson , et al. March 28, 2 | 2017-03-28 |
Treatment Using Dantrolene App 20160243083 - Anderson; David ;   et al. | 2016-08-25 |
Stabilized formulations of peptides and proteins protecting against non-enzymatic degradation Grant 9,394,339 - Anderson July 19, 2 | 2016-07-19 |
Treatment Using Dantrolene App 20160074366 - Anderson; David ;   et al. | 2016-03-17 |
Treatment using dantrolene Grant 9,271,964 - Anderson , et al. March 1, 2 | 2016-03-01 |
Stabilized Formulations Of Peptides And Proteins App 20140378655 - Anderson; David | 2014-12-25 |
Method for protection of peptides or proteins against non-enzymatic deamidation Grant 8,858,927 - Anderson October 14, 2 | 2014-10-14 |
Compositions for binding to assay substrata and methods of using Grant 8,728,829 - Anderson , et al. May 20, 2 | 2014-05-20 |
Treatment Methods with Low-Dose, Longer-Acting Formulations of Local Anesthetics and Other Agents App 20140105989 - Anderson; David ;   et al. | 2014-04-17 |
Treatment Using Dantrolene App 20140099382 - Anderson; David ;   et al. | 2014-04-10 |
Treatment using dantrolene Grant 8,685,460 - Anderson , et al. April 1, 2 | 2014-04-01 |
Treatment using dantrolene Grant 8,604,072 - Anderson , et al. December 10, 2 | 2013-12-10 |
Stabilized uncoated particles of reversed liquid crystalline phase materials Grant 8,449,863 - Anderson May 28, 2 | 2013-05-28 |
Treatment Using Dantrolene App 20120121663 - Anderson; David ;   et al. | 2012-05-17 |
Treatment Using Dantrolene App 20120121662 - Anderson; David ;   et al. | 2012-05-17 |
Stabilized uncoated particles of reversed liquid crystalline phase materials Grant 8,128,905 - Anderson March 6, 2 | 2012-03-06 |
Stabilized uncoated particles of reversed liquid crystalline phase materials Grant 8,128,906 - Anderson March 6, 2 | 2012-03-06 |
Treatment using dantrolene Grant 8,110,225 - Anderson , et al. February 7, 2 | 2012-02-07 |
Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use Grant 7,968,124 - Anderson , et al. June 28, 2 | 2011-06-28 |
Compositions for binding to assay substrata and methods of using Grant 7,838,307 - Anderson , et al. November 23, 2 | 2010-11-23 |
Formulations of quaternary ammonium neuromuscular blocking agents Grant 7,838,515 - Anderson November 23, 2 | 2010-11-23 |
Treatment using dantrolene Grant 7,758,890 - Anderson , et al. July 20, 2 | 2010-07-20 |
Treatment Using Dantrolene App 20100160400 - Anderson; David ;   et al. | 2010-06-24 |
Stabilized uncoated particles of reversed liquid crystalline phase materials Grant 7,713,440 - Anderson May 11, 2 | 2010-05-11 |
Coated particles, methods of making and using Grant 7,105,229 - Anderson September 12, 2 | 2006-09-12 |
Particles with improved solubilization capacity Grant 6,991,809 - Anderson January 31, 2 | 2006-01-31 |
Coated particles, methods of making and using Grant 6,989,195 - Anderson January 24, 2 | 2006-01-24 |
Coated particles, methods of making and using Grant 6,638,621 - Anderson October 28, 2 | 2003-10-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.